Cencora (WBO:ABC) Interest Expense: €-408 Mil (TTM As of Mar. 2026)

What is Cencora Interest Expense?

Cencora WBO:ABC -0.27% 69 Interest Expense is €-408 Mil as of Mar. 2026. GuruFocus rates WBO:ABC with a GF Score™ of 69/100 and a GF Value™ of €259.48 (Fairly Valued). The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cencora's interest expense for the three months ended in Mar. 2026 was € -134 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-408 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cencora's Operating Income for the three months ended in Mar. 2026 was € 1,178 Mil. Cencora's Interest Expense for the three months ended in Mar. 2026 was € -134 Mil. Cencora's Interest Coverage for the quarter that ended in Mar. 2026 was 8.82. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cencora (WBO:ABC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cencora's Interest Expense for the three months ended in Mar. 2026 was €-134 Mil. Its Operating Income for the three months ended in Mar. 2026 was €1,178 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €10,604 Mil.

Cencora's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	1177.687	/	-133.505
	=	8.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Cencora Interest Expense Historical Data

* Premium members only.

The historical data trend for Cencora's Interest Expense can be seen below:

Cencora Interest Expense Chart

Cencora Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

Interest Expense

Get a 7-Day Free Trial

-147.96

-212.78

-214.51

-224.06

-357.63

Cencora Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-122.39	-101.35	-93.17	-79.73	-133.51

69GF Score

Cencora Inc WBO:ABC

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cencora Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-408 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of €-408 Mil mean?

Cencora (WBO:ABC) has a Interest Expense of €-408 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cencora and its competitors.

Is Cencora's Interest Expense too high?

Cencora's current Interest Expense is €-408 Mil. Overall, Cencora has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Cencora's Interest Expense compare to CAH and MCK?

Cencora's Interest Expense of €-408 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Distribution company?

A good Interest Expense depends on the Medical Distribution industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cencora and its competitors. Cencora's current Interest Expense is €-408 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cencora stock overvalued right now?

Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €259.48, compared to a current price of €254.30 — trading 2% below its estimated fair value. The current Interest Expense is €-408 Mil. Cencora's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Interest Expense is €-408 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (WBO:ABC) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be undervalued. The current stock price of €254.30 is trading 2% below its estimated GF Value™ of €259.48. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for WBO:ABC:

Interest Expense: €-408 Mil
GF Value™: €259.48 vs. price of €254.30 (2% below fair value)
GF Score™: 69/100 with 1 warning sign

No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cencora Business Description

Industry Healthcare Medical Distribution

Comparable Companies CAH MCK HSIC AHG ACH FOCL YI COSM HKPD SNYR ASX:SIG SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP SHSE:600511

Other Exchanges COR:USA COR:Mexico 1COR:Italy 0HF3:UK ABG:Germany C1CO34:Brazil

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800

Website https://www.cencora.com

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

69GF Score

Get the complete analysis for WBO:ABC

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€254.30

Price

€259.48

GF Value

View WBO:ABC Analysis

See Interest Expense data for all stocks →